121 related articles for article (PubMed ID: 14991952)
41. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
42. Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.
Mu DQ; Peng YS; Xu QJ
World J Gastroenterol; 2004 Feb; 10(4):471-5. PubMed ID: 14966900
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool.
Mulcahy H; Farthing MJ
Ann Oncol; 1999; 10 Suppl 4():114-7. PubMed ID: 10436800
[TBL] [Abstract][Full Text] [Related]
44. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
45. Cellular kinetics and K-ras codon 12 mutations according to histomorphometric type of colorectal polyps with epithelial serrated proliferation.
Hamatani S; Wada R; Morita A; Hasegawa C; Mitsuda A; Hatori T; Nonaka H; Takahashi K; Gomi S; Shibuya K
Oncol Rep; 2005 Jul; 14(1):121-7. PubMed ID: 15944778
[TBL] [Abstract][Full Text] [Related]
46. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.
Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer.
Kazmi HR; Chandra A; Nigam J; Noushif M; Parmar D; Gupta V
Dig Surg; 2013; 30(3):233-9. PubMed ID: 23838952
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
[TBL] [Abstract][Full Text] [Related]
49. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
Nollau P; Moser C; Weinland G; Wagener C
Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
[TBL] [Abstract][Full Text] [Related]
50. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
[TBL] [Abstract][Full Text] [Related]
51. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
52. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study.
Slattery ML; Curtin K; Anderson K; Ma KN; Edwards S; Leppert M; Potter J; Schaffer D; Samowitz WS
Cancer Res; 2000 Dec; 60(24):6935-41. PubMed ID: 11156393
[TBL] [Abstract][Full Text] [Related]
53. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
[TBL] [Abstract][Full Text] [Related]
54. Characterization of a novel oncogenic K-ras mutation in colon cancer.
Akagi K; Uchibori R; Yamaguchi K; Kurosawa K; Tanaka Y; Kozu T
Biochem Biophys Res Commun; 2007 Jan; 352(3):728-32. PubMed ID: 17150185
[TBL] [Abstract][Full Text] [Related]
55. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer.
Samowitz WS; Holden JA; Curtin K; Edwards SL; Walker AR; Lin HA; Robertson MA; Nichols MF; Gruenthal KM; Lynch BJ; Leppert MF; Slattery ML
Am J Pathol; 2001 Apr; 158(4):1517-24. PubMed ID: 11290569
[TBL] [Abstract][Full Text] [Related]
56. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.
Jiang W; Kahn SM; Guillem JG; Lu SH; Weinstein IB
Oncogene; 1989 Jul; 4(7):923-8. PubMed ID: 2666911
[TBL] [Abstract][Full Text] [Related]
57. [K-ras gene mutation in gallbladder carcinoma].
Roa JC; Roa I; de Aretxabala X; Melo A; FarÃa G; Tapia O
Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
[TBL] [Abstract][Full Text] [Related]
58. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.
Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM
Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229
[TBL] [Abstract][Full Text] [Related]
59. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
[TBL] [Abstract][Full Text] [Related]
60. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
